Trial Profile
A Phase II, Single-center, Randomized, Controlled, Double-blind Study to Assess Effects on Skin Conditions and Patient Reported Outcome of a Topical Formulation Containing LAS41002 on Lesional Skin in Patients With Atopic Eczema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Eczema
- Focus Therapeutic Use
- Sponsors Almirall S.A.
- 15 Oct 2014 New trial record